Taiwan - Delayed Quote TWD
Grape King Bio Ltd (1707.TW)
136.00
0.00
(0.00%)
At close: 1:30:17 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
11,064,781
11,160,005
10,635,464
10,391,231
9,798,246
Cost of Revenue
2,513,942
2,502,450
2,099,450
1,909,186
1,942,319
Gross Profit
8,550,839
8,657,555
8,536,014
8,482,045
7,855,927
Operating Expense
6,110,020
6,157,698
6,036,873
5,929,212
5,543,773
Operating Income
2,440,819
2,499,857
2,499,141
2,552,833
2,312,154
Net Non Operating Interest Income Expense
43,178
46,929
45,066
17,556
2,276
Pretax Income
2,601,737
2,673,305
2,660,620
2,687,878
2,414,906
Tax Provision
490,944
502,152
519,109
518,191
466,917
Net Income Common Stockholders
1,398,065
1,448,299
1,452,728
1,457,112
1,300,423
Diluted NI Available to Com Stockholders
1,398,065
1,448,299
1,452,728
1,457,112
1,300,423
Basic EPS
9.44
9.78
9.81
9.84
8.81
Diluted EPS
9.38
9.71
9.74
9.78
8.76
Basic Average Shares
148,164.95
148,137
148,137
148,137
147,553
Diluted Average Shares
148,975.78
149,162
149,122
149,062
148,400
Total Expenses
8,623,962
8,660,148
8,136,323
7,838,398
7,486,092
Net Income from Continuing & Discontinued Operation
1,398,065
1,448,299
1,452,728
1,457,112
1,300,423
Normalized Income
1,399,028.01
1,448,299
1,452,728
1,457,112
1,300,882.79
Interest Income
46,578
49,965
47,604
19,923
6,287
Interest Expense
3,400
3,036
2,538
2,367
4,011
Net Interest Income
43,178
46,929
45,066
17,556
2,276
EBIT
2,605,137
2,676,341
2,663,158
2,690,245
2,418,917
EBITDA
3,134,692
3,189,825
3,122,921
3,139,883
2,846,370
Reconciled Cost of Revenue
2,513,942
2,502,450
2,099,450
1,909,186
1,942,319
Reconciled Depreciation
529,555
513,484
459,763
449,638
427,453
Net Income from Continuing Operation Net Minority Interest
1,398,065
1,448,299
1,452,728
1,457,112
1,300,423
Total Unusual Items Excluding Goodwill
-1,187
--
--
-1,096
-570
Total Unusual Items
-1,187
--
--
-1,096
-570
Normalized EBITDA
3,135,879
3,189,825
3,122,921
3,139,883
2,846,940
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-223.99
0
0
0
-110.21
12/31/2021 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1720.TW Standard Chemical & Pharmaceutical Co. Ltd.
58.60
+0.34%
3705.TW YungShin Global Holding Corporation
61.80
-0.16%
4119.TW SCI Pharmtech, Inc.
70.80
+1.72%
1731.TW Maywufa Company Ltd.
22.75
-0.66%
4105.TWO TTY Biopharm Company Limited
75.60
+0.53%
1795.TW Lotus Pharmaceutical Co., Ltd.
227.00
+1.79%
1789.TW ScinoPharm Taiwan, Ltd.
19.10
0.00%
6472.TW Bora Pharmaceuticals Co., LTD.
733.00
+3.53%
4746.TW Formosa Laboratories, Inc.
67.80
+2.73%
6446.TW PharmaEssentia Corporation
508.00
+2.21%